The stock market slashed weekly gains Friday, but Nvidia has a new buy point. Tesla deliveries for Q4 and 2024 loom.

But stocks with attractive dividend yields might also be appropriate for you, depending on your investment goals. Investors holding shares of companies that pay dividends can look forward to ...

But software stocks have surged in the second half of the year, and many software companies have been putting up strong numbers. Shares of Palantir Technologies Inc. PLTR have quadrupled so far in ...

Nvidia is IBD Stock Of The Day as the AI chipmaker rises above its 50-day moving average and a downward-sloping trendline.

AppLovin is the IBD Stock Of The Day as the app marketing platform earns positive reviews for its nascent e-commerce ...

PFE issues its financial guidance for 2025. MRK and ABBV announce M&A deals. SNY/TEVA's IBD drug succeeds in a phase IIb ...

Israel's Teva Pharmaceutical Industries and French drugmaker Sanofi said a study of a drug to treat ulcerative colitis and ...

Teva Pharmaceutical (NYSE: TEVA) and Sanofi (NASDAQ: SNY) stocks were rising on Tuesday after the companies announced successful results of a phase 2 study involving the treatment of patients with ...

In a report released today, Sam Slutsky from LifeSci Capital maintained a Buy rating on Spyre Therapeutics (SYRE – Research Report), with a ...

Teva Pharmaceuticals' shares soared and Sanofi's stock moved higher following positive results from the latest trial of their jointly developed treatment for inflammatory bowel disease.

Teva and Sanofi's Phase 2b RELIEVE UCCD study shows duvakitug improves remission in ulcerative colitis and response in ...